Methods for the accurate estimation of confidence intervals on protein folding φ‐values [PDF]
Ingo Ruczinski +2 more
openalex +1 more source
Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy
ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan +3 more
wiley +1 more source
"Omics" and Postmortem Interval Estimation: A Systematic Review. [PDF]
Secco L +7 more
europepmc +1 more source
Interval estimation for operating characteristic of continuous biomarkers with controlled sensitivity or specificity. [PDF]
Huang Y, Parakati I, Patil DH, Sanda MG.
europepmc +1 more source
Learning-Based Intermittent CSI Estimation with Adaptive Intervals in Integrated Sensing and Communication Systems [PDF]
Jie Chen, Xianbin Wang
openalex +1 more source
Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler +20 more
wiley +1 more source
Redefining <i>postmortem</i> interval estimation: the need for evidence-based research to bridge science and justice. [PDF]
Teixeira MJ +3 more
europepmc +1 more source
Partners in Postmortem Interval Estimation: X-ray Diffraction and Fourier Transform Spectroscopy. [PDF]
Rubio L +3 more
europepmc +1 more source
Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito +14 more
wiley +1 more source

